Pasithea Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for KTTA stock has a target of 40, which predicts an increase of 452.49% from the current stock price of 7.24.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$40	$40	$40	$40
Change	+452.49%	+452.49%	+452.49%	+452.49%

* Price targets were last updated on Jul 10, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for KTTA is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	2	2	2	2	1
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Elemer Piros EF Hutton	EF Hutton	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+452.49%	Jul 10, 2023
Elemer Piros EF Hutton	EF Hutton	Strong Buy Initiates $40	Strong Buy	Initiates	$40	+452.49%	Jun 1, 2023
Constantine Davides EF Hutton	EF Hutton	Strong Buy Maintains $46 → $40	Strong Buy	Maintains	$46 → $40	+452.49%	Apr 3, 2023
Constantine Davides EF Hutton	EF Hutton	Strong Buy Initiates $65	Strong Buy	Initiates	$65	+797.79%	Dec 14, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

from -13.01

EPS Next Year

n/a

Year	2020	2021	2022	2023
Revenue	-	15.06K	-	-
Revenue Growth	-	-	-	-
EPS	-	-4.20	-11.03	-13.01
EPS Growth	-	-	-	-
No. Analysts	-	-	-	-

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.